Free provider profile

ANAS KHANFAR, M.D

NPI 1881982494
Individual
Internal Medicine, Medical Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like ANAS KHANFAR?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What ANAS KHANFAR prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Imbruvica
  • Xtandi
  • Lenalidomide
  • Revlimid
  • Zejula

See all hematologist-oncologists in MN who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

507-217-5000

Fax

507-233-1327

Practice address

1217 8TH ST N, NEW ULM, MN, 56073

Registry updated
2026-01-27
NPI issued
2011-07-17
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

1217 8TH ST N, NEW ULM, MN, 56073

507-217-5000

Single practice location

Enumerated 2011-07-17

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — 2 taxonomies listed — broader service mix.
  • — Record updated within the last year.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,851

Medicare patients

266

Part D drug cost

$2,835,134

Brand-name share

13.6%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Imbruvica (Ibrutinib)26$431,662
Xtandi (Enzalutamide)23$311,811
Revlimid (Lenalidomide)17$291,957
Lenalidomide (Lenalidomide)20$279,958
Zejula (Niraparib Tosylate)12$210,428
Tagrisso (Osimertinib Mesylate)12$198,324
Ibrance (Palbociclib)12$192,757
Mekinist (Trametinib Dimethyl Sulfoxide)12$112,091

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across MN — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.